APA (7th ed.) Citation

MKP, R., L, S., N, S., A, D., B, D., I, P., . . . M, C. (2024). Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial. Cureus, 16(5), e60162. https://doi.org/10.7759/cureus.60162

Chicago Style (17th ed.) Citation

MKP, Rao, et al. "Efficacy and Safety of Amorolfine Lotion 0.25% W/v Compared to Amorolfine Cream 0.25% W/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial." Cureus 16, no. 5 (2024): e60162. https://doi.org/10.7759/cureus.60162.

MLA (9th ed.) Citation

MKP, Rao, et al. "Efficacy and Safety of Amorolfine Lotion 0.25% W/v Compared to Amorolfine Cream 0.25% W/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial." Cureus, vol. 16, no. 5, 2024, p. e60162, https://doi.org/10.7759/cureus.60162.